-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Better Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2020 to Q3 2023.
- Better Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$5.86M, a 48.6% increase year-over-year.
- Better Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$31.6M, a 29.7% increase year-over-year.
- Better Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$39.8M, a 1.43% increase from 2021.
- Better Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$40.3M, a 532% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)